Metabolic Dysfunction-associated Steatotic Liver Disease
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatotic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients [NA]
Ongoing clinical trial evaluating a new ultrasound system for non-invasive assessment of liver steatosis in MASLD/MASH patients.
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Study on the Function of Taiwan Green Propolis in Reducing Blood Lipids and Body Fat in Sub-healthy Groups: MASLD [NA]
A clinical trial registry entry evaluating whether Taiwan Green Propolis can lower blood lipids and reduce body fat in individuals with MASL…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Lifestyle Habits and Metabolic Dysfunction-Associated Steatotic Liver Disease in Youth
A completed clinical trial by Harokopio University studied the relationship between lifestyle habits and Metabolic Dysfunction-Associated St…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]
ClinicalTrials.gov listing for a recruiting study evaluating the effects of pectin supplementation on systemic inflammation, the gut microbi…
-
CLINICAL_TRIALS withdrawal · 2025-07-25Clinical Trial Update: Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD [NA]
A clinical trial evaluating a digital therapeutic lifestyle intervention for metabolic dysfunction-associated steatotic liver disease (MASLD…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
This clinical trial aims to predict recompensation in patients with decompensated cirrhosis using spleen stiffness measurements and simple b…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0) [NA]
Clinical trial NCT07083336 is evaluating the Liver Fat-targeted CMNT diet as a dietary intervention for adults with Type 2 Diabetes Mellitus…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Prognostic Model for MASLD Related Cirrhosis
Clinical trial update describing a prognostic model for MASLD-related cirrhosis; the study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
A clinical trial update reports recruiting participants to evaluate a non-invasive screening tool for predicting metabolic dysfunction-assoc…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]
A clinical trial update describes a study evaluating normobaric hypoxic training for metabolic dysfunction-associated steatotic liver diseas…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Digital Early Warning System for Acute Lung Injury in Liver Surgery
A ClinicalTrials.gov entry describing a study of a digital early warning system to detect acute lung injury in patients undergoing liver sur…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update evaluating pegylated interferon alfa-2b in combination with nucleos(t)ide analogues for chronic hepatitis B, w…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016) [Phase 2]
Merck's Phase 2 trial MK-6024-016 evaluating alternate dosing in adults with metabolic dysfunction-associated steatotic liver disease and no…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Effect of Tirzepatide on Markers of MASLD in Patients With Obesity [EARLY_Phase 1]
An early-phase trial evaluating the effect of tirzepatide on markers of metabolic dysfunction-associated steatotic liver disease in adults w…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database
This completed real-world study assesses implementing the MASH patient care pathway in a Chinese population using the Meinian Health Check-u…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease. [Phase 2]
Phase 2 clinical trial evaluating the effect of a sinbiotic with multispecies probiotics on liver parameters in patients with MASLD/MASH; tr…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Effects of Different Exercises on Intrahepatic Lipid in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease [NA]
An ongoing clinical trial is assessing how different exercise programs affect intrahepatic lipid in patients with metabolic dysfunction-asso…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
A clinical trial update indicates a study examining whether accelerated biological aging is associated with an increased risk of Type 2 Diab…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia
A clinical trial update suggests that metabolically healthy obesity may increase the risk of metabolic dysfunction-associated steatotic live…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease [NA]
A clinical trial evaluating the effect of in-place slow jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease; the study is cu…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: The Effects of Dihydromiricetin on MASLD [NA]
A clinical trial evaluating Dihydromiricetin for nonalcoholic fatty liver disease (MASLD) has completed, according to ClinicalTrials.gov, sp…
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH [Phase 3]
Phase 3 study evaluating denifanstat for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associat…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD. [NA]
A clinical trial update indicates an ongoing, invitation-only study evaluating the impact of pedometer-motivated physical activity on MASLD …
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Reducing Barriers to Lifestyle Modification for Newly Diagnosed MASLD [NA]
A Stanford-sponsored clinical trial update describes efforts to reduce barriers to lifestyle modification for people newly diagnosed with me…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Hepatic Elastography-Enhanced Lifestyle Modification in MASLD [NA]
Ongoing clinical trial update shows enrollment by invitation for a hepatic elastography-enhanced lifestyle modification program in MASLD pat…